Merck MRK
NYSE MRK
$145.93 +0.74 (+0.51%)
As of: Oct 16, 2026 · 3:59 PM EDT

Merck (MRK) Accumulated Expenses (2009 - 2011)

Updated

Merck's Accumulated Expenses came in at $8.56 billion for Q1 2011, up 1.4% from $8.44 billion a year earlier and up 0.5% from the prior quarter.

Analysis

Merck (MRK) Accumulated Expenses (2009 - 2011) Analysis & Trends

At the end of FY2010, Merck's Accumulated Expenses was $8.51 billion, down 10.0% from FY2009.

  • Going back by year, Accumulated Expenses was $9.46 billion in FY2009.
  • The Q1 2011 figure represents the highest quarterly Accumulated Expenses since Q4 2009.
  • Business Quant data shows MRK's Accumulated Expenses at $8.51 billion (Q4 2010), $8.16 billion (Q3 2010) and $6.83 billion (Q2 2010) in the three quarters before Q1 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 8.56 Bn
Dec 31, 2010 8.51 Bn
Sep 30, 2010 8.16 Bn
Jun 30, 2010 6.83 Bn
Mar 31, 2010 8.44 Bn
Dec 31, 2009 9.46 Bn
API Access

Merck Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MRK&period=max&api_key=YOUR_API_KEY